COVID-19 Vaccine Responses in PIDD Subjects
Learn more about:
Related Clinical Trial
COVID-19 Vaccine Responses in PIDD Subjects
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases